Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joaquim I Silveira da Mota Neto"'
Autor:
Maurício Silva de Lima, Gilda Paoliello, Rodrigo Machado Vieira, Bernardo Garcia de Oliveira Soares, Ygor Arzeno Ferrão, Joaquim I Silveira da Mota Neto, Douglas Allen Schirmer, Claudio Meneghello Martins, Fernando Madalena Volpe
Publikováno v:
Revista Brasileira de Psiquiatria. 29:246-249
OBJECTIVES: The Clinical Global Impression - Schizophrenia Scale was designed to assess severity and treatment response in subjects with schizophrenia involved in naturalistic studies and daily clinical practice. The objective of this study is to val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a99c31b067749b7558a627265ae87c7
https://doi.org/10.1590/s1516-44462006005000047
https://doi.org/10.1590/s1516-44462006005000047
Autor:
Joaquim I Silveira da Mota Neto, Heike Hunger, Stefan Leucht, Franziska Schmid, Werner Kissling, Christine Rummel-Kluge, Sandra Schwarz, Katja Komossa
Publikováno v:
The Cochrane Library
In many countries of the industrialised world second generation (atypical) antipsychotics have become first line drug treatments for people with schizophrenia. The question as to whether, and if so how much, the effects of the various second generati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727683452726f757f45f34302389f616
https://pubmed.ncbi.nlm.nih.gov/20091599
https://pubmed.ncbi.nlm.nih.gov/20091599
Publikováno v:
The Cochrane Library
Background The treatment of schizophrenia with old, 'typical' antipsychotic drugs such as haloperidol can be problematic, because many people treated with these drugs will suffer from movement disorders. Amisulpride is said to be an "atypical" antips
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6070c7ce81e1a5d7db3345505f35608
https://doi.org/10.1002/14651858.cd001357
https://doi.org/10.1002/14651858.cd001357
Publikováno v:
The Cochrane Library
Background Medication is the mainstay of treatment for schizophrenia. Many people with schizophrenia, however, continue to experience symptoms in spite of medication and may experience side effects that are unwanted and unpleasant. In addition to med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4861c90a04b7ed7396f500cb742eb747
https://doi.org/10.1002/14651858.cd000524
https://doi.org/10.1002/14651858.cd000524
